AKT1 and breast cancer: In 2016, Peng et al. (2016) proposed that ginsenoside Rg3 promoted apoptosis in BC cells by interfering with the level of mammaglobin A in MDA-MB-231 cells, and this effect was achieved by affecting PI3K/AKT signaling pathway activity.